Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

ARTAÇ, MEHMET; Bozcuk, Hakan; Kiyici, Aysel; Eren, Orhan; Boruban, Melih; Ozdogan, Mustafa

doi:10.1007/s12282-011-0322-1

Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

ARTAÇ M., Bozcuk H., Kiyici A., Eren O. O., Boruban M. C., Ozdogan M.

BREAST CANCER, cilt.20, sa.2, ss.174-180, 2013 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 20 Sayı: 2
Basım Tarihi: 2013
Doi Numarası: 10.1007/s12282-011-0322-1
Dergi Adı: BREAST CANCER
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.174-180
Anahtar Kelimeler: Metastatic breast cancer, Leptin, Waist-to-hip ratio, Weight, Aromatase inhibitors, Hormonal therapy, BODY-MASS-INDEX, PLASMA LEPTIN, FACTOR-ALPHA, OBESITY, WOMEN, MECHANISMS, ADIPONECTIN, METABOLISM, EXPRESSION, TAMOXIFEN
Akdeniz Üniversitesi Adresli: Evet

Özet

Our objective was to determine whether serum leptin levels and obesity-related factors could affect outcome for metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs).